Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Martinez

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
AIDS Patient Care and Stds|April 13, 2007
Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot studyAraceli Rousaud, Jordi Blanch, Martin Hautzinger, et al.
Antiviral Therapy|November 21, 2007
Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophyGiovanni Guaraldi, Kety Luzi, Rita Murri, et al.
AIDS (London, England)|June 18, 2009
Continuous antiretroviral therapy decreases bone mineral densityBirgit Grund, Grace Peng, Cynthia L Gibert, et al.
The Lancet. HIV|December 1, 2023
Ageism: the -ism affecting the lives of older people living with HIVGiovanni Guaraldi, Jovana Milic, Mario Cascio, et al.
AIDS (London, England)|January 9, 2010
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parametersEsteban Martinez, Fehmida Visnegarwala, Birgit Grund, et al.
AIDS (London, England)|October 7, 2025
Inhibition of Th1-type immune responses in persons with HIV with current statin exposureAndreas Dehlbæk Knudsen, Marco Gelpi, Moises A Suarez-Zdunek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1Jordi Blanch, Araceli Rousaud, Esteban Martinez, et al.
AIDS (London, England)|November 25, 2011
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudyAdrian Curran, Esteban Martinez, Maria Saumoy, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitorsBluma G Brenner, Réjean Thomas, José Luis Blanco, et al.
Antiviral Therapy|March 31, 2011
Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosisAlejandro Arenas-Pinto, Alison Grant, Krishnan Bhaskaran, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
AIDS Patient Care and Stds|April 13, 2007
Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot studyAraceli Rousaud, Jordi Blanch, Martin Hautzinger, et al.
Antiviral Therapy|November 21, 2007
Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophyGiovanni Guaraldi, Kety Luzi, Rita Murri, et al.
AIDS (London, England)|June 18, 2009
Continuous antiretroviral therapy decreases bone mineral densityBirgit Grund, Grace Peng, Cynthia L Gibert, et al.
The Lancet. HIV|December 1, 2023
Ageism: the -ism affecting the lives of older people living with HIVGiovanni Guaraldi, Jovana Milic, Mario Cascio, et al.
AIDS (London, England)|January 9, 2010
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parametersEsteban Martinez, Fehmida Visnegarwala, Birgit Grund, et al.
AIDS (London, England)|October 7, 2025
Inhibition of Th1-type immune responses in persons with HIV with current statin exposureAndreas Dehlbæk Knudsen, Marco Gelpi, Moises A Suarez-Zdunek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1Jordi Blanch, Araceli Rousaud, Esteban Martinez, et al.
AIDS (London, England)|November 25, 2011
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudyAdrian Curran, Esteban Martinez, Maria Saumoy, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2016
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitorsBluma G Brenner, Réjean Thomas, José Luis Blanco, et al.
Antiviral Therapy|March 31, 2011
Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosisAlejandro Arenas-Pinto, Alison Grant, Krishnan Bhaskaran, et al.
Pageof 17